Health Care

Commentary

Congress should put Medicare out of its misery now

As Republican leaders in Congress prepare to negotiate over the federal budget with their Democratic counterparts in the aftermath of the election, it’s time for everyone to face a hard truth — we must end Medicare as we know it. The entitlement is bleeding to death. Without major changes, it ...
Commentary

Obamacare vs. the Constitution: Part Deux

Is the Supreme Court ready to go a second round with Obamacare? Last week, the justices signaled that they just might be. That’s good news for opponents of the law — and bad news for those still struggling to defend it. And it’s a reminder of how much is at ...
Commentary

Obamacare’s Cruel War On Patient-Centered Healthcare

In just a few weeks, when the calendar flips to 2013, millions of Americans will get their first taste of Obamacare — a $2,500 cap on their flexible spending accounts. That’s down from the previous $5,000 cap — and thus equivalent to a tax hike for any family that had ...
Commentary

States looking to exchange Obamacare’s insurance exchanges

The next act in the Obamacare saga is about to begin — and it’s going to be tragic. December 14 marks the deadline for states to reveal their plans for constructing insurance exchanges in line with the healthcare law’s dictates. Many are opting out — leaving the federal government to ...
Commentary

A free market will help fix health care

Neurologists are about to feel the sting of the Affordable Care Act. Beginning Jan. 1, Medicare will be paying them less for electrodiagnostic procedures used in identifying and treating a wide range of nerve and muscle disorders. Reimbursement rates for some tests will be slashed by more than 50 percent, ...
Commentary

Obamacare’s Rationers Employ The “It’s Good For You” Defense

Obamacare’s backers have a plan to justify their attempts to ration medicine — by saying that it’s good for you. Through 2019, the Patient Protection and Affordable Care Act — otherwise known as Obamacare — will allocate some $3.5 billion toward “Comparative Effectiveness Research,” or CER, which pits drug versus ...
Commentary

Obamacare’s doctor depression

Thanks to Obamacare, America’s corps of doctors appears to have a case of the blues. The Physicians Foundation recently asked more than 13,000 doctors about their morale, their career plans, their practices and their views of the Affordable Care Act. The results were grim. Nearly six in 10 doctors said ...
Business & Economics

New Report on Controlling Rising Government Compensation Costs

New Report on Controlling Rising Government Compensation Costs The Pacific Research Institute (PRI), a free-market think tank based in San Francisco, today released a new report providing policy reforms to help control the rising compensation costs of state government employees. The report “Policy Reforms to Control Rising Government Compensation Costs” ...
Health Care

Benefits from Orphan Drug Research Outweigh Costs

PRI RELEASES PRIMER ON ORPHAN DRUG MARKET BENEFITS FROM ORPHAN DRUG RESEARCH OUTWEIGH COSTS A new study from the Pacific Research Institute reviews the economics of the orphan drug market and determines that the benefits from continued orphan drug research outweigh the costs. The report “A Primer on the Orphan ...
Commentary

To Cure Rare Diseases, Unleash Orphan Drug Innovations

Last month, the City of Pittsburgh hosted the 35th annual Great Race, a charity run that raises money for the Richard S. Caliguiri Amyloidosis Research Fund. Caliguiri, a former Pittsburgh mayor, died of this rare protein disorder, and a portion of the race proceeds are used to help find a ...
Commentary

Congress should put Medicare out of its misery now

As Republican leaders in Congress prepare to negotiate over the federal budget with their Democratic counterparts in the aftermath of the election, it’s time for everyone to face a hard truth — we must end Medicare as we know it. The entitlement is bleeding to death. Without major changes, it ...
Commentary

Obamacare vs. the Constitution: Part Deux

Is the Supreme Court ready to go a second round with Obamacare? Last week, the justices signaled that they just might be. That’s good news for opponents of the law — and bad news for those still struggling to defend it. And it’s a reminder of how much is at ...
Commentary

Obamacare’s Cruel War On Patient-Centered Healthcare

In just a few weeks, when the calendar flips to 2013, millions of Americans will get their first taste of Obamacare — a $2,500 cap on their flexible spending accounts. That’s down from the previous $5,000 cap — and thus equivalent to a tax hike for any family that had ...
Commentary

States looking to exchange Obamacare’s insurance exchanges

The next act in the Obamacare saga is about to begin — and it’s going to be tragic. December 14 marks the deadline for states to reveal their plans for constructing insurance exchanges in line with the healthcare law’s dictates. Many are opting out — leaving the federal government to ...
Commentary

A free market will help fix health care

Neurologists are about to feel the sting of the Affordable Care Act. Beginning Jan. 1, Medicare will be paying them less for electrodiagnostic procedures used in identifying and treating a wide range of nerve and muscle disorders. Reimbursement rates for some tests will be slashed by more than 50 percent, ...
Commentary

Obamacare’s Rationers Employ The “It’s Good For You” Defense

Obamacare’s backers have a plan to justify their attempts to ration medicine — by saying that it’s good for you. Through 2019, the Patient Protection and Affordable Care Act — otherwise known as Obamacare — will allocate some $3.5 billion toward “Comparative Effectiveness Research,” or CER, which pits drug versus ...
Commentary

Obamacare’s doctor depression

Thanks to Obamacare, America’s corps of doctors appears to have a case of the blues. The Physicians Foundation recently asked more than 13,000 doctors about their morale, their career plans, their practices and their views of the Affordable Care Act. The results were grim. Nearly six in 10 doctors said ...
Business & Economics

New Report on Controlling Rising Government Compensation Costs

New Report on Controlling Rising Government Compensation Costs The Pacific Research Institute (PRI), a free-market think tank based in San Francisco, today released a new report providing policy reforms to help control the rising compensation costs of state government employees. The report “Policy Reforms to Control Rising Government Compensation Costs” ...
Health Care

Benefits from Orphan Drug Research Outweigh Costs

PRI RELEASES PRIMER ON ORPHAN DRUG MARKET BENEFITS FROM ORPHAN DRUG RESEARCH OUTWEIGH COSTS A new study from the Pacific Research Institute reviews the economics of the orphan drug market and determines that the benefits from continued orphan drug research outweigh the costs. The report “A Primer on the Orphan ...
Commentary

To Cure Rare Diseases, Unleash Orphan Drug Innovations

Last month, the City of Pittsburgh hosted the 35th annual Great Race, a charity run that raises money for the Richard S. Caliguiri Amyloidosis Research Fund. Caliguiri, a former Pittsburgh mayor, died of this rare protein disorder, and a portion of the race proceeds are used to help find a ...
Scroll to Top